Rojin Park, M.D.
Blood Res 2013; 48(4): 235-236Hye Lim Jung, M.D. Ph.D.
Blood Res 2013; 48(4): 237-239Kyoung Il Jo, Rojin Park, and Jong Ho Won
Blood Res 2013; 48(4): 240Hyung-Seok Yang, Kyung Sam Cho, and Tae Sung Park
Blood Res 2013; 48(4): 241Antonio Mori, Sara Deola, Luciano Xumerle, Vladan Mijatovic, Giovanni Malerba, and Vladia Monsurrò
Blood Res 2013; 48(4): 242-249Hee-Jeong Lee, Hyung-Jin Park, Hyun-Wook Kim, and Sang-Gon Park
Blood Res 2013; 48(4): 250-253Hae-Ryong Kang, Yong-hoon Kwon, Eun-Sun Yoo, Kyung-Ha Ryu, Ji Yoon Kim, Heung-Sik Kim, Hwang Min Kim, and Young-Ho Lee
Blood Res 2013; 48(4): 254-257Goni Lee, Seung Eun Lee, Kyung-Ha Ryu, and Eun Sun Yoo
Blood Res 2013; 48(4): 258-265Hee Sang Hwang, Dok Hyun Yoon, Cheolwon Suh, Chan-Sik Park, and Jooryung Huh
Blood Res 2013; 48(4): 266-273Jieun Lee, Chul Yong Kim, Young Je Park, and Nam Kwon Lee
Blood Res 2013; 48(4): 274-281
Comparison of progression-free survival between patients treated with sequential chemotherapy followed by radiotherapy (SCRT, dotted line) and those treated with concurrent chemoradiotherapy (CCRT, solid line) (
Comparison of overall survival between patients treated with sequential chemotherapy followed by radiotherapy (SCRT, dotted line) and those treated with concurrent chemoradiotherapy (CCRT, solid line) (